A.J.S. Rayl's article on the possibility of an oral treatment for multiple sclerosis 1 (MS) once again points out the need for new thinking about the causes and treatments for MS. For over 50 years, ...

In the "real world," patients with multiple sclerosis (MS) who experienced relapses while on oral medications did so at a rate comparable to that of clinical trials; however, adverse effects were ...

Two injectable therapies accounted for nearly 100 percent of medications for patients in 2001, but by 2020 that decreased to about 25 percent. The majority of individuals with multiple sclerosis (MS) ...

Fingolimod (FTY720), an immunomodulator that acts on sphingosine-1-phosphate receptors, is the first oral disease-modifying agent to be approved by the US FDA for the treatment of relapsing forms of ...

WASHINGTON (Reuters) - U.S. regulators on Wednesday approved a new multiple sclerosis drug made by Biogen Idec Inc that is widely expected to become the No. 1 oral treatment for the disease, with ...

A small study suggests Mavenclad’s effectiveness in MS may be linked to how regulatory T-cells respond to treatment.

Getting your Trinity Audio player ready... When I was diagnosed with multiple sclerosis, or MS, back in 1988, there were no treatments on the market. The only prescription I received then was a ...

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome—the trillions of bacteria, fungi, and viruses that colonize our digestive tract—and ...

† Referred to as immunomodulatory treatments. ‡ Considered to be an immunosuppressant therapy. CIS: Clinically isolated syndrome; IM: Intramuscular; IV ...

When I was diagnosed with multiple sclerosis, or MS, back in 1988, there were no treatments on the market. The only prescription I received then was a recommendation to go home and rest. It wasn’t ...